
February 08, 2024
Galan Lithium Limited (ACN 149 349 646) (Galan or the Company) is pleased to provide details of its Share Purchase Plan (Plan).
In the ASX announcement dated 31 January 2024, entitled “A$19.5m Raising to Fund Ongoing Development of HMW Phase 1”, Galan announced an $18 million placement to institutional, sophisticated and professional investors (Placement) and a share purchase plan offer of $1.5 million to existing Galan shareholders. Under the Placement, Galan was to issue a total of 39,130,435 fully paid ordinary shares in the Company at $0.46 per share along with 39,130,435 free attaching listed options (exercisable at $0.65 with a 5-year exercise period)(Options).
The Company raised $16.5 million (before costs) and issued an initial 35,869,565 fully paid ordinary shares in the Company on 6 February 2024. The issue of the 35,869,565 free attaching Options will follow in due course. Additionally, some of Galan’s directors will be subscribing for up to 3,260,870 fully paid ordinary shares along with up to 3,260,870 free attaching Options on the same terms raising a total of up to $1.5 million (before costs) in a second tranche that will be subject to shareholder approval at a forthcoming general meeting.
The offer under the Plan (Offer) will be on the same terms as the Placement for the issue of up to 3,260,870 Shares at $0.46 per share (Offer Price), along with up to 3,260,870 free attaching Options to raise up to
$1.5m on the terms and conditions (Terms and Conditions) of the Plan enclosed with this letter.
Under the Plan, Eligible Shareholders (defined below) will have the opportunity to purchase up to $30,000 at the Offer Price irrespective of the size of their shareholding and without incurring brokerage or transaction costs. Shares issued under the Plan will have an Offer Price of $0.46 per Share. One free attaching Option will also be issued on the basis of one (1) Option for every one (1) Share subscribed for and issued under the Plan. The Company will make an application to ASX for quotation of the Options.
The offer of Options under the Placement and the Plan will be made under a transaction specific Prospectus which is anticipated to be lodged with ASIC on 23 February 2024 and will be dispatched to Shareholders on 26 February 2024 (Prospectus).
Click here for the full ASX Release
This article includes content from Galan Lithium, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
GLN:AU
The Conversation (0)
20 April 2025
Galan Lithium
Developing high-grade lithium brine projects in Argentina
Developing high-grade lithium brine projects in Argentina Keep Reading...
24 August 2025
Successful Due Diligence Ends - $20M Placement To Proceed
Galan Lithium (GLN:AU) has announced Successful Due Diligence Ends - $20m Placement To ProceedDownload the PDF here. Keep Reading...
01 August 2025
Final At-The-Market Raise for 2025
Galan Lithium (GLN:AU) has announced Final At-The-Market Raise for 2025Download the PDF here. Keep Reading...
30 July 2025
Quarterly Activities and Cash Flow Report
Galan Lithium (GLN:AU) has announced Quarterly Activities and Cash Flow ReportDownload the PDF here. Keep Reading...
25 July 2025
Incentive Regime for HMW Project in Argentina
Galan Lithium (GLN:AU) has announced Incentive Regime for HMW Project in ArgentinaDownload the PDF here. Keep Reading...
24 July 2025
Trading Halt
Galan Lithium (GLN:AU) has announced Trading HaltDownload the PDF here. Keep Reading...
21 January
Official signing of the Portuguese State Grant
Savannah joins other grant recipient companies at official signing ceremony
Savannah Resources Plc, the developer of the Barroso Lithium Project in Portugal, a 'Strategic Project' under the European Critical Raw Materials Act and Europe's largest spodumene lithium deposit (the 'Project'), was delighted to join with other recipients of State grants yesterday at the... Keep Reading...
21 January
Excellent Results from 2025 Core Drilling Program at McDermitt
Jindalee Lithium Limited (Jindalee, or the Company; ASX: JLL, OTCQX: JNDAF) is pleased to report assay results from the drilling program at the McDermitt Lithium Project completed late 2025. All holes returned strong lithium and magnesium intercepts from shallow depths, including:R92: 36.5m @... Keep Reading...
08 January
Top 5 US Lithium Stocks (Updated January 2026)
The global lithium market enters 2026 after a punishing 2025 marked by oversupply, weaker-than-expected EV demand and sustained price pressure, although things began turning around for lithium stocks in Q4. Lithium carbonate prices in North Asia fell to four-year lows early in the year,... Keep Reading...
07 January
5 Best-performing ASX Lithium Stocks (Updated January 2026)
Global demand for lithium presents a significant opportunity for Australia and Australian lithium companies.Australia remains the world’s largest lithium miner, supplying nearly 30 percent of global output in 2024, though its dominance is easing as other lithium-producing countries such as... Keep Reading...
05 January
CEOL Application for Laguna Verde Submitted
CleanTech Lithium PLC ("CleanTech Lithium" or "CleanTech" or the "Company") (AIM: CTL, Frankfurt:T2N), an exploration and development company advancing sustainable lithium projects in Chile, is pleased to announce it has submitted its application (the "Application") for a Special Lithium... Keep Reading...
29 December 2025
SQM, Codelco Seal Landmark Lithium Joint Venture in Salar de Atacama
Sociedad Quimica y Minera (SQM) (NYSE:SQM) and Codelco have finalized their long-awaited partnership, forming a new joint venture that will oversee lithium production in Chile’s Salar de Atacama through 2060.SQM announced on Saturday (December 27) that it has completed its strategic partnership... Keep Reading...
Latest News
Interactive Chart
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00







